Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-22

Clinical Trial Update: A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating ingested cannabidiol in healthy occasional cannabis users has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Cannabis | Phase 1, Phase 2 | Status: COMPLETED